Loading viewer...
conference
Format: PDF conference
Moderna presents an overview of its oncology pipeline and mRNA-based immuno-oncology programs at ASCO 2024. The presentation discusses clinical development advancement, efficacy and safety of vaccine and therapeutic candidates, and the potential of oncology programs to address unmet medical needs through collaborative partnerships.
conference
25 Pages
conference
43 Pages
Unknown
Blueknight Energy Partners 2016 Citi MLP Midstream Conference
conferenceconference
26 Pages
Blueknight Energy Partners